Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge

被引：18

作者：

Gray, NS ^{[1
]}

机构：

[1] Allegheny Gen Hosp, Allegheny Ctr 4, Dept Psychiat, Pittsburgh, PA 15212 USA

来源：

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 2004年 / 19卷 / 03期

关键词：

neuroleptic malignant syndrome; Parkinson's disease; ziprasidone; antipsychotic agents; dopamine;

D O I：

10.1002/hup.578

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom overlap can occur, is discussed. Copyright (C) 2004 John Wiley Sons, Ltd.

引用

页码：205 / 207

页数：3

共 15 条

[1] SEROTONIN SYNDROME [J].

BODNER, RA ;

LYNCH, T ;

LEWIS, L ;

KAHN, D .

NEUROLOGY, 1995, 45 (02) :219-223

[2] The neuroleptic malignant and serotonin syndromes [J].

Carbone, JR .

EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2000, 18 (02) :317-+

[3]

CAROFF SN, 1988, PSYCHOPHARMACOL BULL, V24, P25

[4]

CASTILLO E, 1989, AM J PSYCHIAT, V146, P324

[5]

CLARK T, 1986, INT J PSYCHIAT MED, V15, P299

[6]

DELAY J, 1965, Bull Mem Soc Med Hop Paris, V116, P487

[7]

DURRAINI KK, 2002, JEFFERSON J PSYCHIAT, V17, P11

[8] Neuroleptic malignant syndrome in advanced Parkinson's disease [J].

Gordon, PH ;

Frucht, SJ .

MOVEMENT DISORDERS, 2001, 16 (05) :960-962

[9] NEUROLEPTIC MALIGNANT SYNDROME - DETECTION AND MANAGEMENT [J].

LAZARUS, A .

PSYCHIATRIC ANNALS, 1985, 15 (12) :706-712

[10]

LEVENSON JL, 1985, AM J PSYCHIAT, V142, P1137

← 1 2 →